Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

October 27, 2018
0

Novartis announced today that the full data from the LIBERTY study of Aimovig (erenumab) in episodic migraine patients who had tried and failed two to four prior preventive treatments have been published in the Lancet.

Source link

Early Antibiotics and Childhood Obesity: Do Future Risks Matter to Parents and Physicians?

How hibernators could help humans treat illness, conserve energy and get to Mars

You may also like

Fox4ward: Boosting Memory with Electrical Current

June 24, 2019
0

There’s lots of talk these

Read more

Does helicobacter pylori predispose to Parkinson’s disease?

June 24, 2019
0

H. pylori and Parkinson’s disease:

Read more